Remedium Bio, Inc. announces research agreement to evaluate platform technology in Diabetes with the University of Massachusetts Boston
January 10, 2022
|
Portfolio Update
SHARE ARTICLE
Get in touch
Contact us for more information about how we can help you invest in healthcare, biotech, climate tech, or advanced systems.